NDC 61958-2401 – Vosevi
Sofosbuvir 400 mg/1; Velpatasvir 100 mg/1; Voxilaprevir 100 mg/1 · Tablet, Film Coated · Oral
Product NDC61958-2401
Product details
- Brand name
- Vosevi
- Generic name
- SOFOSBUVIR, VELPATASVIR, and VOXILAPREVIR
- Labeler
- Gilead Sciences, Inc.
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- NDA · NDA209195
- Marketed since
- July 18, 2017
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis C Virus NS3/4A Protease Inhibitor; Hepatitis C Virus NS5A Inhibitor; Hepatitis C Virus Nucleotide Analog NS5B Polymerase Inhibitor
Active ingredients
- Sofosbuvir 400 mg/1
- Velpatasvir 100 mg/1
- Voxilaprevir 100 mg/1
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61958-2401-1 | 28 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-2401-1) | Jul 18, 2017 |
Recalls mentioning this NDC
- D-0759-2018 May 16, 2018 · Class II
Lack of Processing Controls.